The Europe Cryostat Market would witness market growth of 4.3% CAGR during the forecast period (2022-2028).
Cryostats are used to maintain frozen tissue, sliced tissue sections thin enough even for microscopic examination, and offer a rapid diagnosis for a number of illnesses and medical disorders, including neuromuscular illnesses. They can also be utilized to examine the histochemistry of enzymes. The whole procedure is carried out in a cryogenic environment.
Five components make up a cryostat, and they each perform crucial tasks for various types of investigations. These include the blade holder, specimen holder, microtome, freezing chamber or shelf, and anti-roll guides. Tissues must first be prepared before being studied. When working with tissues, that melt, crack, wrinkle, tear, or otherwise degenerate, cryo-sectioning is the best option. Optimal cutting temperature chemicals, glue, or paraffin must be used to embed the tissue prior to sectioning.
One can use OCT to test the settings before beginning the cutting process to ensure that they are accurate. By doing this, one can learn how to operate the equipment without wasting priceless samples. The conservation of cell density as well as tissue architecture, which is crucial in the identification of neurosurgical materials, particularly in the case of unevenly infiltrating gliomas, is a benefit of cryostat-cut frozen sections.
The development of cancer detection procedures and treatments has long been a priority for the United Kingdom. It continues to play a critical role in cancer early diagnosis, dramatically raising patient survival rates all over the world. It has a strong cancer diagnostics and treatment business. One in two persons in the UK may receive a cancer diagnosis at some point in their lives. The NHS in the U.K. records 980 cancer cases each day. These rising cases of cancer would support the market growth for cryostat in this region due to the increased need for microtomes.
The Germany market dominated the Europe Cryostat Market by Country in 2021; thereby, achieving a market value of $190.3 million by 2028. The UK market is exhibiting a CAGR of 3.5% during (2022 - 2028). Additionally, The France market would experience a CAGR of 5.1% during (2022 - 2028).
Based on Application, the market is segmented into Healthcare, Biotechnology & Forensic Science, Energy & Power, Metallurgy, Aerospace & Defense and Marine Biology. Based on Type, the market is segmented into Continuous-flow, Closed-Cycle, Bath and Multistage. Based on System Component, the market is segmented into Dewars, High Vacuum Pumps, Temperature Controllers, Gas Flow Pumps, Transfer Tubes and Microtome Blades. Based on countries, the market is segmented into Germany, UK, France, Russia, Spain, Italy, and Rest of Europe.
Free Valuable Insights: The Global Cryostat Market will Hit $3 Billion by 2028, at a CAGR of 5.1%
The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Danaher Corporation (Leica Biosystems), MEDITE Medical GmbH, Bright Instruments Limited, Amos scientific Pty Ltd., SLEE medical GmbH, Advanced Research Systems, Inc., Lake Shore Cryotronics, Inc., Cryomech, Inc., Dakewe Biotech Co., Ltd. and Jinhua YIDI Medical Appliance Co., Ltd.
By Cryogen
By Application
By Type
By System Component
By Country
Unique Offerings Our team of dedicated experts can provide you with attractive expansion opportunities for your business.
